Compass Therapeutics Inc. CMPX
$1.99
▲ +1.00% 24H
About
Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing proprietary antibody therapeutics, primarily in oncology. The company engages the immune system to treat multiple human diseases, with its scientific orientation centered on the relationship between angiogenesis, the immune sy…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees39
TickerCMPX
Statistics
Market Cap$357.5M
Revenue (TTM)$0
Net Income-$66.5M
Net Margin—
EPS—
P/E-4.82
P/S—
P/B1.96
EV/EBITDA-2.41
ROE-45.9%
Dividend Yield—
Price$1.99
Data: Twelve Data · Revenue = mcap / P/S